Variations of Proline-Rich Kinase Pyk2 Expression Correlate with Prostate Cancer Progression

[1]  W. Marston,et al.  Overexpression of the focal adhesion kinase (p125FAK) in the vascular smooth muscle cells of intimal hyperplasia. , 2001, Journal of vascular surgery.

[2]  W. Xie,et al.  Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the noble rat , 2000, The Prostate.

[3]  E. Reiter,et al.  Genes upregulated during castration‐induced rat prostatic apoptosis: cloning and characterization of new cDNAs , 2000, BJU international.

[4]  H. Ueda,et al.  Suppression of Pyk2 Kinase and Cellular Activities by Fip200 , 2000, The Journal of cell biology.

[5]  H. Husson,et al.  RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells , 1999, Oncogene.

[6]  Y. Hsieh,et al.  Racial differences in prostate cancer related to loss of heterozygosity on chromosome 8p12-23. , 1999, International journal of radiation oncology, biology, physics.

[7]  T. Udayakumar,et al.  Culture of prostate epithelial cells of the rhesus monkey on extracellular matrix substrate: influence of steroids and insulin-like growth factors. , 1999, The Journal of endocrinology.

[8]  J. Moul.  Angiogenesis, p53, bcl-2 and Ki-67 in the Progression of Prostate Cancer after Radical Prostatectomy , 1999, European Urology.

[9]  William Arbuthnot Sir Lane,et al.  Tyrosine kinase Pyk2 mediates G-protein-coupled receptor regulation of the Ewing sarcoma RNA-binding protein EWS , 1999, Current Biology.

[10]  M. Burdick,et al.  Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. , 1999, The American journal of pathology.

[11]  P. Majumder,et al.  Activation of p38 Mitogen-activated Protein Kinase by PYK2/Related Adhesion Focal Tyrosine Kinase-dependent Mechanism* , 1999, The Journal of Biological Chemistry.

[12]  C. Dinney,et al.  Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  P. Majumder,et al.  Bcl-xL Blocks Activation of Related Adhesion Focal Tyrosine Kinase/Proline-rich Tyrosine Kinase 2 and Stress-activated Protein Kinase/c-Jun N-terminal Protein Kinase in the Cellular Response to Methylmethane Sulfonate* , 1999, The Journal of Biological Chemistry.

[14]  T. Visakorpi.  New pieces to the prostate cancer puzzle , 1999, Nature Medicine.

[15]  Noah Craft,et al.  A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase , 1999, Nature Medicine.

[16]  M. Šuša.  Heterotrimeric G proteins as fluoride targets in bone (review). , 1999, International journal of molecular medicine.

[17]  G. Miller,et al.  Molecular genetics and epidemiology of prostate carcinoma. , 1999, Endocrine reviews.

[18]  A. Hagemeijer,et al.  Characterization of chromosome 8 aberrations in the prostate cancer cell line LNCaP-FGC and sublines , 1999, Urological Research.

[19]  J. Trapman,et al.  Identification of a homozygous deletion at 8p12–21 in a human prostate cancer xenograft , 1999, Genes, chromosomes & cancer.

[20]  H. Frierson,et al.  Activation of mitogen-activated protein kinase associated with prostate cancer progression. , 1999, Cancer research.

[21]  T. Hunter,et al.  Pyk2 and Src‐family protein‐tyrosine kinases compensate for the loss of FAK in fibronectin‐stimulated signaling events but Pyk2 does not fully function to enhance FAK− cell migration , 1998, The EMBO journal.

[22]  J. Guan,et al.  Differential stimulation of proline-rich tyrosine kinase 2 and mitogen-activated protein kinase by sphingosine 1-phosphate. , 1998, European journal of biochemistry.

[23]  C. Chatelain,et al.  Androgen Deprivation for Prostatic Carcinoma: A Rationale for Choosing Components , 1998, International journal of urology : official journal of the Japanese Urological Association.

[24]  Zhong-ying Liu,et al.  Human Immunodeficiency Virus Tat Modulates the Flk-1/KDR Receptor, Mitogen-Activated Protein Kinases, and Components of Focal Adhesion in Kaposi’s Sarcoma Cells , 1998, Journal of Virology.

[25]  J. Schlessinger,et al.  Identification of a New Pyk2 Isoform Implicated in Chemokine and Antigen Receptor Signaling* , 1998, The Journal of Biological Chemistry.

[26]  R. Ganju,et al.  The related adhesion focal tyrosine kinase (RAFTK) is tyrosine phosphorylated and participates in colony-stimulating factor-1/macrophage colony-stimulating factor signaling in monocyte-macrophages. , 1998, Blood.

[27]  B. Wullich,et al.  Androgen Receptor Expression, Proliferation Index and Aneuploidy in Tissue Explant Cultures Derived Prostate Carcinoma Cells Co-Cultivated on Membranes , 1998, European Urology.

[28]  P. Stricker,et al.  Growth factor involvement in progression of prostate cancer. , 1998, Clinical chemistry.

[29]  D. Mukhopadhyay,et al.  Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium. , 1998, Cancer research.

[30]  A. Schönthal,et al.  Expression of Human Prostatic Acid Phosphatase Correlates with Androgen-stimulated Cell Proliferation in Prostate Cancer Cell Lines* , 1998, The Journal of Biological Chemistry.

[31]  C. Wood,et al.  Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells. , 1998, British Journal of Cancer.

[32]  R. Ganju,et al.  Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK. , 1998, Blood.

[33]  J. Guan,et al.  Differential Regulation of Pyk2 and Focal Adhesion Kinase (FAK) , 1998, The Journal of Biological Chemistry.

[34]  O. Cussenot,et al.  Androgens are not a direct requirement for the proliferation of human prostatic epithelium in vitro , 1997, International journal of cancer.

[35]  J. Parsons,et al.  Induction of Apoptosis after Expression of PYK2, a Tyrosine Kinase Structurally Related to Focal Adhesion Kinase , 1997, The Journal of cell biology.

[36]  J. Kozlowski,et al.  Intrinsic and extrinsic factors controlling benign prostatic growth , 1997, The Prostate.

[37]  R. Ganju,et al.  Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells. , 1997, The Journal of clinical investigation.

[38]  S. Lev,et al.  A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation , 1996, Nature.

[39]  L. Bégin,et al.  Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma , 1996, International journal of cancer.

[40]  O. Jänne,et al.  Effects of mitogens on androgen receptor-mediated transactivation. , 1996, Endocrinology.

[41]  N. Kakazu,et al.  Precise localization of the human gene encoding cell adhesion kinase β (CAKβ/PYK2) to chromosome 8 at p21.1 by fluorescence in situ hybridization , 1996, Human Genetics.

[42]  S. Lev,et al.  Activation of Pyk2 by Stress Signals and Coupling with JNK Signaling Pathway , 1996, Science.

[43]  S. Chevalier,et al.  Regulation and activation of focal adhesion kinase and paxillin during the adhesion, proliferation, and differentiation of prostatic epithelial cells in vitro and in vivo. , 1996, Molecular endocrinology.

[44]  L. Mazzucchelli,et al.  Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma. , 1996, The American journal of pathology.

[45]  H. Kung,et al.  A tyrosine kinase profile of prostate carcinoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  H. Klocker,et al.  Regulation of prostatic growth and function by peptide growth factors , 1996, The Prostate.

[47]  Terukatsu Sasaki,et al.  Cloning and Characterization of Cell Adhesion Kinase β, a Novel Protein-tyrosine Kinase of the Focal Adhesion Kinase Subfamily (*) , 1995, The Journal of Biological Chemistry.

[48]  E. Peles,et al.  Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions , 1995, Nature.

[49]  W. Cance,et al.  Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. , 1995, Cancer research.

[50]  G. Bubley,et al.  Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. , 1995, The New England journal of medicine.

[51]  Jorma Isola,et al.  In vivo amplification of the androgen receptor gene and progression of human prostate cancer , 1995, Nature Genetics.

[52]  P. Humphrey,et al.  Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate‐specific antigen levels , 1993, Cancer.

[53]  J. Parsons,et al.  pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[54]  M. Key,et al.  Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[55]  C. Eaton,et al.  Regulation of prostatic growth , 1988 .

[56]  S. Hsu,et al.  The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. , 1981, American journal of clinical pathology.

[57]  Daniel S. Miller,et al.  Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. , 2000, Archives of pathology & laboratory medicine.

[58]  R. Vessella,et al.  Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. , 1999, Urology.

[59]  K. Griffiths,et al.  The regulation of prostatic growth , 1996 .

[60]  Myron Tanncnbaum,et al.  Urologic pathology: The prostate , 1977 .

[61]  D. Gleason,et al.  Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. , 1974, The Journal of urology.